Drug Database
Back to search

Poland· PL-100467187

Dulsevia

A duloxetine product containing duloxetinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC N06AX21

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDulseviaATCN06AX21REGISTER NO.PL-100467187PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about duloxetinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Duloxetine is registered in 16 of 19 countries.

Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose
Search duloxetine products by name

Duloxetine · ATC N06AX21

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of duloxetine costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Duloxetine · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.57
  • IT Italy$0.67
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Duloxetinum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N06AX21
ATC class
Duloxetine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

2 priced
  • gtin
    05909991480745
    28 szt.
    PLN 28.39
  • gtin
    05909991480752
    56 szt.
    PLN 52.97
  • gtin
    05909991480721
  • gtin
    05909991480738
  • gtin
    05909991480769

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

501 interactions on record for duloxetine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check duloxetine against other medicinesHow interaction checks work

Duloxetine · interactions on record

501 records

  • 33 severe
  • 247 moderate
  • 23 minor
  • 130 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

68 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06AX21

Duloxetine, as other registers publish it.

All duloxetine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5708359-201a-4846-9200-615770b73c6b
GET /v1/drugs/b5708359-201a-4846-9200-615770b73c6b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki dojelitowe, twarde",
  "source": "urpl",
  "strength": "60 mg",
  "packaging": "05909991480721 ¦ Rp ¦ 144579\n7 kaps.\n05909991480738 ¦ Rp ¦ 144580\n14 kaps.\n05909991480745 ¦ Rp ¦ 144581\n28 kaps.\n05909991480752 ¦ Rp ¦ 144582\n56 kaps.\n05909991480769 ¦ Rp ¦ 144583\n84 kaps.",
  "substance": "Duloxetinum 60 mg",
  "common_name": "Duloxetinum",
  "pl_product_id": "100467187",
  "pozwolenie_nr": "169/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-04-14"
}
API referenceMCP serverPlans

See everything about duloxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console